Subject: RE: REMINDER FW: WHO 2019 survey on access to direct acting antivirals (DAAs)
From: Ekaterine Adamia <[email-masked]>
To: "MAMULASHVILI, Nino" <[email-masked]>
Cc: Tamar Gabunia <[email-masked]>, "[email-masked]" <[email-masked]>, "[email-masked]" <[email-masked]>
Date: Tue, 01 Oct 2019 13:15:53 +0000

Dear Nino,

Please, find attached completed questionnaire.

Best Regards,

Eka

From: MAMULASHVILI, Nino [mailto:[email-masked]]
Sent: 19 September, 2019 14:00
To: Ekaterine Adamia
Subject: FW: REMINDER FW: WHO 2019 survey on access to direct acting antivirals (DAAs)
Importance: High

Dear Ekaterine,

As agreed by phone please find attached questionnaire to be completed.

Thank you in advance.

Kind regards,

Nino

__________________________________

Dr. Nino Mamulashvili

Program Coordinator

WHO Country Office Georgia

Office location: 81 Vasil Barnov Street, 0179 Tbilisi, Georgia

Mailing address: UN House, 9 Rapiel Eristavi Street, 0179 Tbilisi, Georgia

Mobile: +995 599 567 244

E-mail: [email-masked]

GPN: 74212

From: RENAUD, Francoise
Sent: Wednesday, September 11, 2019 12:00 PM
To: MOZALEVSKIS, Antons <[email-masked]>
Cc: PASCUAL MARTINEZ, Fernando <[email-masked]>
Subject: FW: REMINDER FW: WHO 2019 survey on access to direct acting antivirals (DAAs)

Dear Antons, any update from Georgia from your side?

Regards

Françoise

From: RENAUD, Francoise
Sent: Friday, September 6, 2019 5:36 PM
To: [email-masked]; LESI, Olufunmilayo <[email-masked]>; HERMEZ, Joumana George <[email-masked]>; CHAN, Po-lin <[email-masked]>; REWARI, Bharat (Bhushan) <[email-masked]>; MOZALEVSKIS, Antons <[email-masked]>
Cc: DUEÑAS LOAYZA, Erika <[email-masked]>; PASCUAL MARTINEZ, Fernando <[email-masked]>; LOW-BEER, Daniel <[email-masked]>
Subject: REMINDER FW: WHO 2019 survey on access to direct acting antivirals (DAAs)

Dear colleagues,

I am sharing with you an update on the status of the 2019 DAA survey :

-         Countries that have sent the questionnaire back:  Egypt, Malaysia, Morocco, Pakistan, Russia, Ukraine

-         Countries with no response: Brazil, China, Georgia, India, Mongolia, Rwanda, Thailand.

Could you kindly assist us and follow-up with country offices for the remaining questionnaires in your respective region. The deadline is extended to 26 September 2019.

Thank you very much for your collaboration, let us know if you have any questions.

Regards

Françoise

From: "SUCHET, Corinne C.p." <[email-masked]> on behalf of "HIRNSCHALL, Gottfried Otto" <[email-masked]>
Date: Wednesday, 26 June 2019 at 17:08
To: "GALEA, Gauden" <[email-masked]>, "JABBOUR, Jean Yaacoub" <[email-masked]>, "DOMENTE, Silviu" <[email-masked]>, "BEKEDAM, Hendrik Jan" <[email-masked]>, "LO, Ying-Ru Jacqueline" <[email-masked]>, "DIORDITSA, Sergey" <[email-masked]>, "MAHIPALA, Palitha" <[email-masked]>, "VUJNOVIC, Melita" <[email-masked]>, "OLU, Olushayo Oluseun" <[email-masked]>, "KERTESZ, Daniel A." <[email-masked]>, "HABICHT, Jarno" <[email-masked]>, grosssoc <[email-masked]>
Cc: "[email-masked]'" <[email-masked]'>, "[email-masked]" <[email-masked]>, "LESI, Olufunmilayo" <[email-masked]>, "LAGO, Hugues" <[email-masked]>, "HERMEZ, Joumana George" <[email-masked]>, "ATTA, Hoda Youssef" <[email-masked]>, "MOZALEVSKIS, Antons" <[email-masked]>, "DARA, Masoud" <[email-masked]>, "CHAN, Po-lin" <[email-masked]>, "ISHIKAWA, Naoko" <[email-masked]>, "BULTERYS, Marc" <[email-masked]>, "RENAUD, Francoise" <[email-masked]>, "PASCUAL MARTINEZ, Fernando" <[email-masked]>, "BANDA, Mazuwa Andrew" <[email-masked]>, "BALL, Andrew Lee" <[email-masked]>, "LOW-BEER, Daniel" <[email-masked]>, "HIRNSCHALL, Gottfried Otto" <[email-masked]>, "KAWANGUZI, Lydia Mirembe" <[email-masked]>
Subject: WHO 2019 survey on access to direct acting antivirals (DAAs)

Dear colleagues,

The Department of HIV and Global Hepatitis Programme and the Department of Essential Medicines and Health Products in collaboration with the Regional Office HIV/Hepatitis Advisers are updating the  Global Report on Access to Hepatitis C treatment : focus on overcoming barriers in low- and middle- income countries.

As part of this exercise, we would like to assess and update the current use and availability of DAAs in each country and learn from the country experience in the procurement and supply management of hepatitis C medicines, including solutions for addressing any challenges.

The 2018 report is available at the link : https://www.who.int/hepatitis/publications/hep-c-access-report-2018/en/

In order to complete the 2019 survey in your country, we would be grateful if you could kindly contact and transmit the enclosed questionnaire to the national hepatitis programme if any, or the appropriate person who is most knowledgeable about national hepatitis C treatment activities in the country. If you have any queries concerning this questionnaire, please contact Ms Françoise Renaud ([email-masked]) who is the technical officer responsible for this project in the HQ/HIV Department, Geneva.

We would be grateful if your office could assist us in ensuring that the questionnaire is appropriately completed and sent back to ([email-masked]) by Friday 26 July 2019.

We thank you very much for your collaboration.

Kind regards,

Dr Gottfried Hirnschall
Director

Department of HIV and

Global Hepatitis Programme
World Health Organization
Tel: +41 22 791 27 96
e-mail: [email-masked]
www.who.int/hiv

www.who.int/hepatitis

Twitter @GHirnschall